{
    "2021-07-27": [
        [
            {
                "time": "",
                "original_text": "浙商证券维持凯莱英买入评级，凯莱英更新报告：四论业绩确定性加速趋势和长期天花板打开",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "买入评级",
                        "业绩确定性",
                        "加速趋势",
                        "长期天花板"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "行业观察|医药外包止跌回升背后：头部大企业绩纷纷高增CXO行业未来预期到底如何？",
                "features": {
                    "keywords": [
                        "医药外包",
                        "止跌回升",
                        "头部企业",
                        "高增长",
                        "CXO行业",
                        "未来预期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821)：四论业绩确定性加速趋势和长期天花板打开",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "业绩确定性",
                        "加速趋势",
                        "长期天花板"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "CRO概念持续拉升，昭衍新药涨停，博腾股份、凯莱英、康龙化成跟涨。",
                "features": {
                    "keywords": [
                        "CRO概念",
                        "拉升",
                        "昭衍新药",
                        "涨停",
                        "博腾股份",
                        "凯莱英",
                        "康龙化成",
                        "跟涨"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}